Slika na naslovnici

Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?

Background/Aims: Contrast induced nephropathy (CIN) has multifactorial etiopatogenesis including oxidative stress and vasoconstriction. Nebivolol is an antioxidant and has vasodilatatory effect via NO release and may prevent CIN development. We have noticed that a few number of studies that have eva...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Orcun Altunoren (Author), Mehmet Balli (Author), Necmi Eren (Author), Hakan Tasolar (Author), Abdullah Arpaci (Author), Caglar Emre Caglayan (Author), Yasemin Coskun Yavuz (Author), Ozkan Gungor (Author)
Format:	Knjiga
Izdano:	Karger Publishers, 2015-10-01T00:00:00Z.
Teme:	article
Online dostop:	Connect to this object online.
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?
od: Didem Tütüncü Sezal, et al.
Izdano: (2023)

Risk Factors For Contrast Induced Nephropathy in Surgical Intensive Care Unit Patients
od: Coşkun Araz, et al.
Izdano: (2012)

Renal Tubular Acidosis in Patients with Systemic Lupus Erythematosus
od: Necmi Eren, et al.
Izdano: (2020)

Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy
od: Özgür Günebakmaz, et al.
Izdano: (2013)

The effects of boric acid and quercetin on contrast media-induced nephropathy in rats
od: Kenan Yilmaz, et al.
Izdano: (2022)

Current approach to contrast nephropathy
od: Hüsnü Değirmenci, et al.
Izdano: (2020)

Obesity is not associated with contrast nephropathy
od: Navin Jaipaul, et al.
Izdano: (2010)

Editorial: Contrast-induced nephropathy
od: Sinan Aydoğdu
Izdano: (2013)

Contrast Induced Nephropathy - A Review
od: Rajul Rastogi, et al.
Izdano: (2017)

Contrast Induced Nephropathy in ICU settings
od: Raghavendra Vanaki
Izdano: (2018)

Contrast induced nephropathy; recent findings
od: Mardani Saeed, et al.
Izdano: (2013)

Contrast induced nephropathy by interventionist cardiology
od: Dra. Xiomara Castelo Villalón, et al.
Izdano: (2017)

Contrast-induced nephropathy - prevention and treatment
od: Mateusz Bajak, et al.
Izdano: (2024)

The predictive value of the prognostic nutritional index for contrast-induced nephropathy
od: Murat Gucun, et al.
Izdano: (2022)

NEBIVOLOL - ESPECIAL BETA-ADRENOBLOCKER
od: T. Műnzel, et al.
Izdano: (2016)

The Relationship Between Serum Angiopoietin-Like Protein-2 Levels and Arterial Stiffness in Hemodialysis Patients
od: İlyas Öztürk, et al.
Izdano: (2023)

Contrast-induced nephropathy; A literature review
od: Jafar Golshahi, et al.
Izdano: (2014)

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
od: Hongli Wang, et al.
Izdano: (2024)

Fatal Mucormycosis Infection with Coronavirus Disease 2019 in a Kidney Transplant Patient
od: Fatma Betül Güzel, et al.
Izdano: (2023)

Curriculum for the Management of Contrast Media Reactions, Contrast Induced Nephropathy & Nephrogenic Systemic Fibrosis
od: Puneet Bhargava, et al.
Izdano: (2013)

Modulation of TNF‐α, interleukin‐6, and interleukin‐10 by nebivolol-valsartan and nebivolol-lisinopril polytherapy in SHR rats
od: Lezama‐Martinez Diego, et al.
Izdano: (2024)

Rhabdomyolysis in a patient taking nebivolol
od: Ye Jin Kim, et al.
Izdano: (2016)

A New Equation in the Calculation of Osmolality Before and After Hemodialysis Session
od: Muhammed Seyithanoğlu, et al.
Izdano: (2024)

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
od: Sara K. Richter, et al.
Izdano: (2015)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
od: Ina G. Panova, et al.
Izdano: (2023)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
od: Y. V. Gavrilov, et al.
Izdano: (2015)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
od: M. P. Savenkov, et al.
Izdano: (2016)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
od: Y. V. Gavrilov, et al.
Izdano: (2015)

Lichenoid type cutaneous hyperpigmentation induced by nebivolol
od: Abdullah Nabi Aslan, et al.
Izdano: (2017)

Contrast-induced nephropathy (CIN) - epidemiology, risk factors and prevention
od: Jakub Rafał Pierzchała, et al.
Izdano: (2022)

Prevention of contrast induced nephropathy; a cardiology point of view
od: Hashemi Mohammad, et al.
Izdano: (2015)

The Impact of Hydration and Other Strategies in prevention of Contrast-Induced Nephropathy
od: Joanna Wojtania, et al.
Izdano: (2024)

The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin
od: Macaulay Amechi Onuigbo, et al.
Izdano: (2018)

Formulation and evaluation of S-(-)-Amlodipine besylate and nebivolol hydrochloride tablets
od: S A Shaikh, et al.
Izdano: (2010)

FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS
od: Shaikh S.A, et al.
Izdano: (2010)

Optimization and evaluation of transdermal delivery system for nebivolol hydrochloride
od: P V Shelke, et al.
Izdano: (2024)

The Effect of Urine pH and Urinary Uric Acid Levels on the Development of Contrast Nephropathy
od: Gamze Aslan, et al.
Izdano: (2019)

A novel rat model of contrast-induced nephropathy based on dehydration
od: Kun Liu, et al.
Izdano: (2019)

Experimental rat models for contrast-induced nephropathy; a comprehensive review
od: Marlon Perera, et al.
Izdano: (2020)

Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging
od: Li He, et al.
Izdano: (2022)